Anti-Infective Ophthalmic Market

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.

Anti-Infective Ophthalmic Market contains market size and forecasts of Anti-Infective Ophthalmic in global, including the following market information:

Global Anti-Infective Ophthalmic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anti-Infective Ophthalmic Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Anti-Infective Ophthalmic companies in 2021 (%)

The global Anti-Infective Ophthalmic market was valued at 1510.6 million in 2021 and is projected to reach US$ 1877.9 million by 2028, at a CAGR of 3.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibacterial Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-Infective Ophthalmic include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Infective Ophthalmic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Infective Ophthalmic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Infective Ophthalmic Market Segment Percentages, by Type, 2021 (%)

Antibacterial

Antiviral

Antifungal

Anti-Parasitic

Others

Global Anti-Infective Ophthalmic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Infective Ophthalmic Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Household

Others

Global Anti-Infective Ophthalmic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-Infective Ophthalmic Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-Infective Ophthalmic revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Anti-Infective Ophthalmic revenues share in global market, 2021 (%)

Key companies Anti-Infective Ophthalmic sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Anti-Infective Ophthalmic sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Novartis

Allergan

Valeant Pharmaceuticals

Santen Pharmaceutical

Lupin Pharmaceuticals

Apotex

Akorn